Which signs and symptoms suggest interferon alfa therapy-related cutaneous manifestation in patients with hepatitis C virus (HCV) infection?

Updated: Mar 26, 2021
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print

Erosive OLP and epidermolytic hyperkeratosis may occur with interferon alfa therapy for chronic hepatitis C infection. [76] Capillaritis may be present with interferon alfa treatment of chronic hepatitis C infection. [77] Lichen myxedematosus may worsen during interferon alfa-2a therapy for chronic active hepatitis. Finally, thyroiditis may occur during interferon therapy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!